Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Monoclonal antibody IE5 for detecting new castle disease virus variation strain

A monoclonal antibody and Newcastle disease virus technology, applied in the field of monoclonal antibody 1E5 and diagnostic reagents, can solve the problems of antigenic variation and differences in research results, etc.

Inactive Publication Date: 2009-03-04
INST OF ANIMAL SCI & VETERINARY MEDICINE SHANDONG ACADEMY OF AGRI SCI
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, domestic NDV molecular epidemiological research results have shown that the popular NDV in my country has both old genotypes (such as genotype II) and new genotypes (such as genotype VII). However, the new genotype NDV Has the antigenicity of the virus changed? Due to different experimental conditions and experimental strains in different laboratories, the research results are quite different

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody IE5 for detecting new castle disease virus variation strain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] 1. Establishment of monoclonal antibody 1E5 hybridoma cell line:

[0024] Purified NDV LaSota strain was used as immunogen to obtain monoclonal antibody 1E5 positive clone through cell fusion and indirect ELISA screening, and subcloned it three times to make its ELISA positive rate reach 100%. The hybridoma cells were expanded and cultured and frozen in liquid nitrogen tanks.

[0025] 2. Preparation of monoclonal antibody 1E5 ascites: 8-10 week-old BALB / C mice were intraperitoneally injected with sterile liquid paraffin oil 0.5ml / mouse, and 7 days later, intraperitoneally injected 500,000 / mouse of positive hybridoma cells in logarithmic growth phase. Observed every day that the abdomen of the mouse was obviously enlarged, the ascites was extracted and centrifuged, and the supernatant was taken, and stored at -20°C for later use. About 5ml of ascites can be harvested from each mouse.

[0026] 3. Biological specific identification of monoclonal antibody 1E5:

[0027] 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a monoclonal antibody for detecting new-castle disease virus variant. The preparation method comprises the following steps: immunizing a BALB / C mouse of eight ages using purified new-castle disease virus NDV LaSota strain as immunogen, boostering immnunization, standing for three days, and taking mouse splenic cells to fuse with myeloma cells SP2 / 0 in a logarithmic growth phase. The purified NDV LaSota strain is antigen coated enzyme marking board for screening positive Hybridoma cell, and the monoclone 1E5 is positive via ELISA detection, and is subcloned, and then injected into an abdominal cavity of a sensitized BALB / C mouse of 8 to 10 ages for preparing ascites. The mab bioactivity identification result indicates that mab 1E5 ascites has ELISA titer of 100 multiply 2<10>, immunoglobulin subclass of IgG2a, HI titer of 14log2, and cell neutralization titer for NDV standard virulent strain F48E8 of 320. The monoclonal antibody can be used for antigenic variation research of the new-castle disease virus to monitor and forecast epidemic situation of new castle disease, and provide scientific theoretical basis for the effective prevention and control of the new castle disease.

Description

technical field [0001] The patent of the present invention relates to a diagnostic reagent in the field of veterinary biotechnology, specifically a monoclonal antibody 1E5 for detecting variant strains of Newcastle disease virus. Background technique [0002] Newcastle disease (ND) is a highly contagious and highly contagious disease of poultry, which has caused serious economic losses to the poultry industry in many countries. The causative agent of Newcastle disease is Newcastle disease virus (NDV), a member of the Paramyxoviridae family Mumpsvirus, and a single-stranded non-segmented RNA virus with an envelope. The hemagglutinin-neuraminidase (HN) and fusion protein (F) on the surface of NDV are the main immunoprotective antigens and are closely related to the pathogenicity of the virus. HN protein mainly mediates virus recognition of cell surface receptors, F protein promotes the fusion of viral envelope and cell membrane, and HN protein also participates in the process...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/10G01N33/577
Inventor 张秀美胡北侠黄艳艳何叶峰刘玉庆张伟颜世敢
Owner INST OF ANIMAL SCI & VETERINARY MEDICINE SHANDONG ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products